Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lehmann

Showing results (541-550 of 582) with videos related to

Pageof 59
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 21, 2016
Liver and Muscle Contribute Differently to the Plasma Acylcarnitine Pool During Fasting and Exercise in HumansG Xu, J S Hansen, X J Zhao, et al.
Ecology Letters|August 8, 2015
Photosynthetic innovation broadens the niche within a single speciesMarjorie R Lundgren, Guillaume Besnard, Brad S Ripley, et al.
Molecular Cell|March 16, 2010
Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cellsTomoo Ogi, Siripan Limsirichaikul, René M Overmeer, et al.
The Journal of Investigative Dermatology|June 29, 2005
Two new XPD patients compound heterozygous for the same mutation demonstrate diverse clinical featuresMitsuo Fujimoto, Suzanne N Leech, Therina Theron, et al.
Brain : a Journal of Neurology|June 24, 2008
Neurological symptoms and natural course of xeroderma pigmentosumAnu Anttinen, Leena Koulu, Eeva Nikoskelainen, et al.
Molecular and Cellular Biology|September 2, 2005
Transcription-associated breaks in xeroderma pigmentosum group D cells from patients with combined features of xeroderma pigmentosum and Cockayne syndromeTherina Theron, Maria I Fousteri, Marcel Volker, et al.
Diabetologia|March 31, 2010
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysisG Schernthaner, A H Barnett, D J Betteridge, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2015
XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiencyChaowan Guo, Yuka Nakazawa, Lisa Woodbine, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patientsBernard C Broughton, Agnes Cordonnier, Wim J Kleijer, et al.
Human Molecular Genetics|November 16, 2001
Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD geneB C Broughton, M Berneburg, H Fawcett, et al.
Pageof 59

Showing results (541-550 of 582) with videos related to

Sort By:
Pageof 59
The Journal of Clinical Endocrinology and Metabolism|September 21, 2016
Liver and Muscle Contribute Differently to the Plasma Acylcarnitine Pool During Fasting and Exercise in HumansG Xu, J S Hansen, X J Zhao, et al.
Ecology Letters|August 8, 2015
Photosynthetic innovation broadens the niche within a single speciesMarjorie R Lundgren, Guillaume Besnard, Brad S Ripley, et al.
Molecular Cell|March 16, 2010
Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cellsTomoo Ogi, Siripan Limsirichaikul, René M Overmeer, et al.
The Journal of Investigative Dermatology|June 29, 2005
Two new XPD patients compound heterozygous for the same mutation demonstrate diverse clinical featuresMitsuo Fujimoto, Suzanne N Leech, Therina Theron, et al.
Brain : a Journal of Neurology|June 24, 2008
Neurological symptoms and natural course of xeroderma pigmentosumAnu Anttinen, Leena Koulu, Eeva Nikoskelainen, et al.
Molecular and Cellular Biology|September 2, 2005
Transcription-associated breaks in xeroderma pigmentosum group D cells from patients with combined features of xeroderma pigmentosum and Cockayne syndromeTherina Theron, Maria I Fousteri, Marcel Volker, et al.
Diabetologia|March 31, 2010
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysisG Schernthaner, A H Barnett, D J Betteridge, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2015
XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiencyChaowan Guo, Yuka Nakazawa, Lisa Woodbine, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patientsBernard C Broughton, Agnes Cordonnier, Wim J Kleijer, et al.
Human Molecular Genetics|November 16, 2001
Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD geneB C Broughton, M Berneburg, H Fawcett, et al.
Pageof 59